Compare · IGAP vs MDLN
IGAP vs MDLN
Side-by-side comparison of Integrity Applications Inc. (IGAP) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IGAP and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 981.6x IGAP ($49.0M).
- MDLN has hit the wire 7 times in the past 4 weeks while IGAP has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for IGAP).
- Company
- Integrity Applications Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $49.0M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 25
Integrity Applications Inc.
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Latest IGAP
- GlucoTrack, Inc. Announces Effectiveness Of Corporate Name Change And Ticker Symbol Change
- GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 51 Biggest Movers From Yesterday
- Integrity Applications Issues Shareholder Update Letter
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M